Maze Therapeutics, Inc. (MAZE) stock
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$34.33−1.76 (-4.88%)
Close on Nov 13, 2026Market cap $1.91BP/E –Yield –
Maze Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Maze Therapeutics's operating margin for the twelve months ending Dec 31, 2024 was 34.4%. For fiscal 2024 it was 34.4%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 34.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -132.8% | – |
| Q3 FY2024 | Sep 30, 2024 | -969.2% | – |
| Q2 FY2024 | Jun 30, 2024 | 84.6% | – |
See a number that looks wrong?